Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) (REWIND)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT01394952
First received: July 13, 2011
Last updated: October 19, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2018
  Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)